Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy

Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy

Thrombotic microangiopathy (TMA) is a complication that may occur after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) and is conventionally called transplant-associated thrombotic microangiopathy (TA-TMA). Despite the many efforts made to understand the mechanisms of TA-TMA...

Full description

Bibliographic Details
Main Authors: Gianluigi Ardissino, Valentina Capone, Silvana Tedeschi, Luigi Porcaro, Massimo Cugno
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceuticals
Subjects:
hematopoietic stem cell transplantation
thrombotic microangiopathy
complement
eculizumab
narsoplimab
Online Access:https://www.mdpi.com/1424-8247/15/7/845

Internet

https://www.mdpi.com/1424-8247/15/7/845

Similar Items